These data consistently validated that NEAT1 impairs H2O2-induced FLSs-RA cell dysfunction by modulating the miR-338-3p-GLS pathway, presenting NEAT1 as a promising biomarker and molecular target for the diagnosis and treatment of rheumatoid arthritis. The gene discussed is GLS; the disease is rheumatoid arthritis.